Kataoka M, Tsuda T, Kawamura M, Itoh H, Komatsu A, Mogami H, Tanada S, Iio A, Hamamoto K
Department of Radiology, Ehime University School of Medicine.
Nihon Igaku Hoshasen Gakkai Zasshi. 1990 Feb 25;50(2):155-63.
To evaluate the clinical usefulness of gallium-67 scintigraphy in the detection of the gastrointestinal (GI) non-Hodgkin's lymphoma (NHL) and in the assessment of the therapeutic effects, gallium-67 scintigraphy was reviewed on 24 cases (25 lesions; stomach in 20, ileum in 2, and terminal ileum and/or cecum in 3). Twenty-three out of the 25 lesions (92.0%) were detected by gallium-67 scintigraphy, while barium study could detect all of the 25 lesions. The sizes of the gallium-67 negative 2 lesions were the smallest of all (2.5 and 3.0 cm). The tumor size was considered to the most important factor in the detection by gallium-67 scintigraphy, while the histological classification and the location of the tumor were not related to its detectability. Findings in follow-up gallium-67 scintigraphy after therapy on 10 cases were correlated well with the therapeutic effects. These data suggest that gallium-67 scintigraphy is useful for the detection of GI involvement of NHL and for the assessment of therapeutic effects.
为评估镓-67闪烁扫描术在检测胃肠道非霍奇金淋巴瘤（NHL）及评估治疗效果方面的临床实用性，对24例（25个病灶；胃20个、回肠2个、回肠末端和/或盲肠3个）患者的镓-67闪烁扫描术进行了回顾性分析。25个病灶中，23个（92.0%）可通过镓-67闪烁扫描术检测到，而钡剂造影可检测出所有25个病灶。镓-67扫描阴性的2个病灶是所有病灶中最小的（分别为2.5厘米和3.0厘米）。肿瘤大小被认为是镓-67闪烁扫描术检测的最重要因素，而肿瘤的组织学分类和位置与其可检测性无关。10例患者治疗后随访的镓-67闪烁扫描术结果与治疗效果高度相关。这些数据表明，镓-67闪烁扫描术有助于检测NHL的胃肠道受累情况及评估治疗效果。
